CA-HE50
DEAD

Serial Number

79392477

Owner

GENENCELL CO., LTD.

Filing Date

Feb 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CA-HE50 Trademark

Serial Number: 79392477

CA-HE50 is a trademark filed by GENENCELL CO., LTD. on February 14, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GENENCELL CO., LTD.

2105-1 U-Tower, 120, Heungdeokjungang-ro,

Entity Type: 03

Trademark Details

Filing Date

February 14, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for health care; pharmaceutical preparations for the treatment of eye diseases and conditions; plant extracts for pharmaceutical purposes; phytotherapy preparations for medical purposes; medicinal herb extracts; extracts of medicinal plants; pharmaceutical drugs; nutraceuticals for therapeutic purposes; nutraceutical preparations for therapeutic or medical purposes; pain relief medication

Filing History

DEATH OF INTERNATIONAL REGISTRATION
May 28, 2026 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 16, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 30, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 27, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 30, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 30, 2025 ABN2
REFUSAL PROCESSED BY IB
Oct 7, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2024 REPR